Free Trial

Alpha Teknova (TKNO) Competitors

Alpha Teknova logo
$5.68 -0.08 (-1.39%)
Closing price 10/24/2025 04:00 PM Eastern
Extended Trading
$5.62 -0.05 (-0.97%)
As of 10/24/2025 06:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TKNO vs. UPB, SEPN, SANA, COLL, PHAR, BCAX, RAPP, CRON, PGEN, and XNCR

Should you be buying Alpha Teknova stock or one of its competitors? The main competitors of Alpha Teknova include Upstream Bio (UPB), Septerna (SEPN), Sana Biotechnology (SANA), Collegium Pharmaceutical (COLL), Pharming Group (PHAR), Bicara Therapeutics (BCAX), Rapport Therapeutics (RAPP), Cronos Group (CRON), Precigen (PGEN), and Xencor (XNCR). These companies are all part of the "pharmaceutical products" industry.

Alpha Teknova vs. Its Competitors

Upstream Bio (NASDAQ:UPB) and Alpha Teknova (NASDAQ:TKNO) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, valuation, profitability, analyst recommendations, risk, dividends and earnings.

Alpha Teknova has higher revenue and earnings than Upstream Bio.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Upstream Bio$2.37M497.25-$62.81MN/AN/A
Alpha Teknova$37.74M8.05-$26.75M-$0.42-13.52

In the previous week, Alpha Teknova had 2 more articles in the media than Upstream Bio. MarketBeat recorded 6 mentions for Alpha Teknova and 4 mentions for Upstream Bio. Upstream Bio's average media sentiment score of 0.62 beat Alpha Teknova's score of 0.41 indicating that Upstream Bio is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Upstream Bio
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Alpha Teknova
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Upstream Bio currently has a consensus price target of $53.33, indicating a potential upside of 143.98%. Alpha Teknova has a consensus price target of $10.00, indicating a potential upside of 76.06%. Given Upstream Bio's higher probable upside, equities analysts plainly believe Upstream Bio is more favorable than Alpha Teknova.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Upstream Bio
1 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.67
Alpha Teknova
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.67

13.8% of Alpha Teknova shares are owned by institutional investors. 13.6% of Upstream Bio shares are owned by company insiders. Comparatively, 12.5% of Alpha Teknova shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Alpha Teknova has a net margin of -55.24% compared to Upstream Bio's net margin of -3,836.58%. Alpha Teknova's return on equity of -26.51% beat Upstream Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Upstream Bio-3,836.58% -35.90% -26.26%
Alpha Teknova -55.24%-26.51%-18.40%

Summary

Alpha Teknova beats Upstream Bio on 8 of the 13 factors compared between the two stocks.

Get Alpha Teknova News Delivered to You Automatically

Sign up to receive the latest news and ratings for TKNO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TKNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TKNO vs. The Competition

MetricAlpha TeknovaMED IndustryMedical SectorNASDAQ Exchange
Market Cap$303.97M$3.46B$6.21B$10.81B
Dividend YieldN/A2.28%5.72%4.80%
P/E Ratio-13.5228.5131.6030.99
Price / Sales8.05497.40595.06133.64
Price / CashN/A46.9537.2561.86
Price / Book3.6610.4012.056.61
Net Income-$26.75M-$52.83M$3.34B$277.10M
7 Day Performance10.72%2.10%1.94%2.57%
1 Month Performance-6.43%10.17%6.88%3.20%
1 Year Performance-16.35%16.57%56.06%33.22%

Alpha Teknova Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TKNO
Alpha Teknova
1.8535 of 5 stars
$5.68
-1.4%
$10.00
+76.1%
-16.3%$303.97M$37.74M-13.52240News Coverage
Analyst Forecast
UPB
Upstream Bio
1.9073 of 5 stars
$20.08
+2.3%
$56.50
+181.4%
-12.8%$1.06B$2.37M0.0038Analyst Forecast
SEPN
Septerna
1.7356 of 5 stars
$24.09
+4.4%
$26.75
+11.0%
N/A$1.03B$1.08M-2.39N/AAnalyst Forecast
SANA
Sana Biotechnology
2.6552 of 5 stars
$4.34
+0.5%
$7.50
+72.8%
+48.7%$1.03BN/A-4.09380Analyst Forecast
Gap Up
COLL
Collegium Pharmaceutical
3.6736 of 5 stars
$32.04
flat
$42.33
+32.1%
+1.7%$1.01B$631.45M30.81210News Coverage
Analyst Downgrade
PHAR
Pharming Group
2.6405 of 5 stars
$14.61
+2.4%
$30.00
+105.3%
+56.3%$977.71M$297.20M-112.38280News Coverage
Analyst Upgrade
Gap Down
BCAX
Bicara Therapeutics
2.6762 of 5 stars
$18.51
+4.1%
$31.86
+72.1%
-23.8%$971.01MN/A-5.8432Gap Down
RAPP
Rapport Therapeutics
3.1462 of 5 stars
$26.19
-1.2%
$35.33
+34.9%
+7.1%$967.20MN/A-10.48N/APositive News
Analyst Forecast
Gap Up
CRON
Cronos Group
0.9379 of 5 stars
$2.55
+1.6%
N/A+13.5%$961.06M$117.61M51.00450News Coverage
Positive News
Analyst Forecast
PGEN
Precigen
4.3917 of 5 stars
$3.21
+2.9%
$8.25
+157.0%
+409.4%$929.68M$3.92M-7.64190Analyst Forecast
XNCR
Xencor
3.8029 of 5 stars
$13.96
+7.1%
$24.22
+73.5%
-37.6%$929.34M$110.49M-5.82280News Coverage

Related Companies and Tools


This page (NASDAQ:TKNO) was last updated on 10/26/2025 by MarketBeat.com Staff
From Our Partners